Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06161571
PHASE3

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Sponsor: Akero Therapeutics, Inc

View on ClinicalTrials.gov

Summary

The aim of this study is to assess the safety and tolerability of EFX compared to placebo in subjects with non-invasively diagnosed NASH/MASH and NAFLD/MASLD.

Official title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

700

Start Date

2023-11-10

Completion Date

2026-06-19

Last Updated

2026-04-30

Healthy Volunteers

No

Interventions

DRUG

Efruxifermin

Administered by subcutaneous (SC) injection

DRUG

Placebo

Administered by SC injection

Locations (211)

Akero Clinical Study Site

Birmingham, Alabama, United States

Akero Clinical Study Site

Chandler, Arizona, United States

Akero Clinical Study Site

Flagstaff, Arizona, United States

Akero Clinical Study Site

Peoria, Arizona, United States

Akero Clinical Study Site

Tucson, Arizona, United States

Akero Clinical Study Site

Tucson, Arizona, United States

Akero Clinical Study Site

Conway, Arkansas, United States

Akero Clinical Study Site

Jonesboro, Arkansas, United States

Akero Clinical Study Site

Little Rock, Arkansas, United States

Akero Clinical Study Site

North Little Rock, Arkansas, United States

Akero Clinical Study Site

Chula Vista, California, United States

Akero Clinical Study Site

Coronado, California, United States

Akero Clinical Study Site

Cypress, California, United States

Akero Clinical Study Site

Inglewood, California, United States

Akero Clinical Study Site

La Mesa, California, United States

Akero Clinical Study Site

Lancaster, California, United States

Akero Clinical Study Site

Los Angeles, California, United States

Akero Clinical Study Site

Los Angeles, California, United States

Akero Clinical Study Site

Palm Springs, California, United States

Akero Clinical Study Site

San Diego, California, United States

Akero Clinical Study Site

San Diego, California, United States

Akero Clinical Study Site

San Francisco, California, United States

Akero Clinical Study Site

Santa Maria, California, United States

Akero Clinical Study Site

Englewood, Colorado, United States

Akero Clinical Study Site

Bradenton, Florida, United States

Akero Clinical Study Site

Brandon, Florida, United States

Akero Clinical Study Site

Fort Myers, Florida, United States

Akero Clinical Study Site

Gainesville, Florida, United States

Akero Clinical Study Site

Hialeah Gardens, Florida, United States

Akero Clinical Study Site

Inverness, Florida, United States

Akero Clinical Study Site

Jacksonville, Florida, United States

Akero Clinical Study Site

Lady Lake, Florida, United States

Akero Clinical Study Site

Lakewood Rch, Florida, United States

Akero Clinical Study Site

Largo, Florida, United States

Akero Clinical Study Site

Maitland, Florida, United States

Akero Clinical Study Site

Miami, Florida, United States

Akero Clinical Study Site

Miami Lakes, Florida, United States

Akero Clinical Study Site

Naples, Florida, United States

Akero Clinical Study Site

Ocala, Florida, United States

Akero Clinical Study Site

Port Orange, Florida, United States

Akero Clinical Study Site

Sarasota, Florida, United States

Akero Clinical Study Site

The Villages, Florida, United States

Akero Clinical Study Site

Venice, Florida, United States

Akero Clinical Study Site

Viera, Florida, United States

Akero Clinical Study Site

West Palm Beach, Florida, United States

Akero Clinical Study Site

Winter Park, Florida, United States

Akero Clinical Study Site

Winter Park, Florida, United States

Akero Clinical Study Site

Columbus, Georgia, United States

Akero Clinical Study Site

Gainesville, Georgia, United States

Akero Clinical Study Site

Marietta, Georgia, United States

Akero Clinical Study Site

South Bend, Indiana, United States

Akero Clinical Study Site

West Des Moines, Iowa, United States

Akero Clinical Study Site

Topeka, Kansas, United States

Akero Clinical Study Site

Wichita, Kansas, United States

Akero Clinical Study Site

Bastrop, Louisiana, United States

Akero Clinical Study Site

Covington, Louisiana, United States

Akero Clinical Study Site

Houma, Louisiana, United States

Akero Clinical Study Site

Marrero, Louisiana, United States

Akero Clinical Study Site

Metairie, Louisiana, United States

Akero Clinical Study Site

New Orleans, Louisiana, United States

Akero Clinical Study Site

Shreveport, Louisiana, United States

Akero Clinical Study Site

Baltimore, Maryland, United States

Akero Clinical Study Site

Glen Burnie, Maryland, United States

Akero Clinical Study Site

Greenbelt, Maryland, United States

Akero Clinical Study Site

South Dartmouth, Massachusetts, United States

Akero Clinical Study Site

Southfield, Michigan, United States

Akero Clinical Study Site

Wyoming, Michigan, United States

Akero Clinical Study Site

Ypsilanti, Michigan, United States

Akero Clinical Study Site

Columbia, Missouri, United States

Akero Clinical Study Site

Kansas City, Missouri, United States

Akero Clinical Study Site

Las Vegas, Nevada, United States

Akero Clinical Study Site

Las Vegas, Nevada, United States

Akero Clinical Study Site

Reno, Nevada, United States

Akero Clinical Study Site

Brick, New Jersey, United States

Akero Clinical Study Site

Florham Park, New Jersey, United States

Akero Clinical Study Site

Somers Point, New Jersey, United States

Akero Clinical Study Site

Sparta, New Jersey, United States

Akero Clinical Study Site

Santa Fe, New Mexico, United States

Akero Clinical Study Site

New York, New York, United States

Akero Clinical Study Site

New York, New York, United States

Akero Clinical Study Site

Chapel Hill, North Carolina, United States

Akero Clinical Study Site

Charlotte, North Carolina, United States

Akero Clinical Study Site

Fayetteville, North Carolina, United States

Akero Clinical Study Site

Morehead City, North Carolina, United States

Akero Clinical Study Site

New Bern, North Carolina, United States

Akero Clinical Study Site

Raleigh, North Carolina, United States

Akero Clinical Study Site

Statesville, North Carolina, United States

Akero Clinical Study Site

Columbus, Ohio, United States

Akero Clinical Study Site

Dayton, Ohio, United States

Akero Clinical Study Site

Springboro, Ohio, United States

Akero Clinical Study Site

Westlake, Ohio, United States

Akero Clinical Study Site

Philadelphia, Pennsylvania, United States

Akero Clinical Study Site

Philadelphia, Pennsylvania, United States

Akero Clinical Study Site

Pittsburgh, Pennsylvania, United States

Akero Clinical Study Site

Columbia, South Carolina, United States

Akero Clinical Study Site

Summerville, South Carolina, United States

Akero Clinical Study Site

Chattanooga, Tennessee, United States

Akero Clinical Study Site

Clarksville, Tennessee, United States

Akero Clinical Study Site

Hermitage, Tennessee, United States

Akero Clinical Study Site

Nashville, Tennessee, United States

And 111 more locations on ClinicalTrials.gov